Pharmaengine Stock Earnings Per Share
| 4162 Stock | TWD 92.10 1.20 1.29% |
PharmaEngine fundamentals help investors to digest information that contributes to PharmaEngine's financial success or failures. It also enables traders to predict the movement of PharmaEngine Stock. The fundamental analysis module provides a way to measure PharmaEngine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PharmaEngine stock.
PharmaEngine |
PharmaEngine Company Earnings Per Share Analysis
PharmaEngine's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current PharmaEngine Earnings Per Share | 2.62 X |
Most of PharmaEngine's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PharmaEngine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, PharmaEngine has an Earnings Per Share of 2.62 times. This is 68.7% lower than that of the Healthcare sector and 154.7% lower than that of the Biotechnology industry. The earnings per share for all Taiwan stocks is 16.03% higher than that of the company.
PharmaEngine Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PharmaEngine's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PharmaEngine could also be used in its relative valuation, which is a method of valuing PharmaEngine by comparing valuation metrics of similar companies.PharmaEngine is currently under evaluation in earnings per share category among its peers.
PharmaEngine Fundamentals
| Return On Equity | 0.0985 | |||
| Return On Asset | 0.0589 | |||
| Profit Margin | 0.54 % | |||
| Operating Margin | 0.53 % | |||
| Current Valuation | 14.42 B | |||
| Shares Outstanding | 143.69 M | |||
| Shares Owned By Insiders | 22.57 % | |||
| Shares Owned By Institutions | 20.72 % | |||
| Price To Book | 4.72 X | |||
| Price To Sales | 24.13 X | |||
| Revenue | 654.84 M | |||
| Gross Profit | 617.76 M | |||
| EBITDA | 555.87 M | |||
| Net Income | 426.03 M | |||
| Book Value Per Share | 26.57 X | |||
| Cash Flow From Operations | 929.67 M | |||
| Earnings Per Share | 2.62 X | |||
| Target Price | 107.0 | |||
| Number Of Employees | 41 | |||
| Beta | 0.99 | |||
| Market Capitalization | 16.74 B | |||
| Total Asset | 4.03 B | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 4.03 B | |||
| Last Dividend Paid | 2.7 |
About PharmaEngine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PharmaEngine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PharmaEngine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PharmaEngine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with PharmaEngine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PharmaEngine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmaEngine will appreciate offsetting losses from the drop in the long position's value.Moving together with PharmaEngine Stock
Moving against PharmaEngine Stock
| 0.84 | 9906 | Hsin Ba Ba Split | PairCorr |
| 0.7 | 6547 | Medigen Vaccine Biologics | PairCorr |
| 0.69 | 4174 | OBI Pharma | PairCorr |
| 0.62 | 6541 | Tanvex BioPharma | PairCorr |
| 0.61 | 4142 | Adimmune Corp | PairCorr |
The ability to find closely correlated positions to PharmaEngine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PharmaEngine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PharmaEngine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PharmaEngine to buy it.
The correlation of PharmaEngine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PharmaEngine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PharmaEngine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PharmaEngine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for PharmaEngine Stock Analysis
When running PharmaEngine's price analysis, check to measure PharmaEngine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaEngine is operating at the current time. Most of PharmaEngine's value examination focuses on studying past and present price action to predict the probability of PharmaEngine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaEngine's price. Additionally, you may evaluate how the addition of PharmaEngine to your portfolios can decrease your overall portfolio volatility.